Estrogen receptor alpha (ESR1) gene amplification status and clinical outcome in tamoxifen-treated postmenopausal patients with endocrine-responsive early breast cancer: An analysis of the prospective ABCSG-6 trial.
Estrogen receptor alpha (ESR1) gene amplification status and clinical outcome in tamoxifen-treated postmenopausal patients with endocrine-responsive early breast cancer: An analysis of the prospective ABCSG-6 trial.
复制标题
他莫昔芬治疗的内分泌反应性早期乳腺癌绝经后患者的雌激素受体 α (ESR1) 基因扩增状态和临床结果：前瞻性 ABCSG-6 试验分析
DOI：
10.1200/jco.2012.30.15_suppl.10501
复制
发表时间：
2012
影响因子：
45.3
通讯作者：
Gnant M
中科院分区：
文献类型：
--
作者：
Singer CF;Holst F;Steurer S;Burandt E;Samonigg H;Jakesz R;Stöger H;Greil R;Dietze O;Sauter G;Filipitz M;Simon R;Gnant M
